Optimal Surgical Treatment Of Fulminant Clostridium Difficile Colitis

Phase

N/A

Condition

Infectious Colitis

Inflammatory Bowel Disease

Clostridium Difficile-associated Diarrhea

Treatment

N/A

Clinical Study ID

NCT01441271

2012-P-000138/1; MGH

Ages > 18
All Genders

Study Summary

The investigators hypothesize that minimally invasive ileal diversion with intraoperative colonic lavage using a high volume polyethylene glycol/electrolyte solution will clear Clostridium difficile infection resulting in eradication of Fulminant C. difficile colitis (FCDC) while preserving the colon. Furthermore, the investigators hypothesize this will reduce morbidity and mortality compared to total abdominal colectomy.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Adult patients >18 years of age
Able to provide informed consent, or presence of a legally authorized representativeable and willing to provide informed consent
Candidates for total abdominal colectomy due to severe, complicated FCDC perconsulting surgeon and team providing care
Subjects must meet criteria for operative management of FCDC (find in detailedprotocol)

Exclusion

Exclusion Criteria:

Children (<18 years of age)
Allergy or hypersensitivity reaction to study medications: Vancomycin, Metronidazole,GoLytely
Intra-operative evidence of colonic perforation
Intra-operative evidence of colonic necrosis
Pregnancy (this will be ruled out by a urine test at the time of indication forsurgery)
Prisoners

Study Design

September 01, 2012

September 30, 2013

Study Description

Clostridium difficile (C. difficile) affects more than 3 million patients per year in the United States, and is increasing in frequency [2-15]. Approximately 8 % of hospitalized patients are infected with C. difficile [12]. Of these patients 3% - 8% will develop the fulminant disease, defined as C. difficile colitis with significant systemic toxic effects and shock, resulting in need for colectomy or death [2].

Fulminant C. difficile colitis (FCDC) is a highly lethal disease with mortality rates ranging between 12% - 80% [2-6,8-15]. A retrospective study in our own institution identified a 35% mortality rate for FCDC [2].

The indications for surgical management of patients with FCDC are not clearly defined, however most advocate surgical intervention in patients with worsening clinical exams, peritonitis, or patients in shock. Total abdominal colectomy (also called subtotal colectomy) with end ileostomy has been advocated as the operation of choice and has been demonstrated to marginally improve survival compared to non-operative management in these critically ill patients. A total abdominal colectomy has many disadvantages. Most important, mortality rates continue to range from 35-80%. Additionally, total abdominal colectomy (subtotal colectomy) can result in significant morbidity, and many survivors will have a permanent ileostomy.

The new treatment option that will be tested in this randomized controlled trial (RCT) may change the standard of care. Based on a small prospective series from Neal and colleagues [1] the investigators propose an alternative surgical approach for the management of FCDC, which may prove a safer and simpler option. Based on the nature of the disease as a bacterial toxin-mediated mucosal inflammatory process with delayed and indirect systemic threats to life, the investigators think that minimally invasive ileal diversion with intraoperative colonic lavage using a high volume polyethylene glycol/electrolyte solution will clear Clostridium difficile infection resulting in eradication of FCDC while preserving the colon.

Connect with a study center

Massachusetts General Hospital
Boston, Massachusetts 02114
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.